Clinical availability of skin biopsy in the diagnosis of Parkinson's disease
Section snippets
Acknowledgements
This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, a Grant for Hirosaki University Institutional Research, and a Grant-in-Aid from Studies on the Development of Diagnostic Technique and Therapies for Lewy Body Disease, the Ministry of Health, Labour and Welfare, Japan (to K.W.). The authors wish to express their gratitude to M. Nakata for her technical assistance.
References (18)
- et al.
Staging of brain pathology related to sporadic Parkinson's disease
Neurobiol. Aging
(2003) - et al.
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
Neurosci. Lett.
(2006) - et al.
α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
Neuropathol. Appl. Neurobiol.
(2006) - et al.
Skin biopsy for assessment of autonomic denervation in Parkinson's disease
J. Neural. Transm.
(2006) - et al.
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
Mov. Disord.
(2008) - et al.
α-Synuclein is phosphorylated in synucleinopathy lesions
Nat. Cell Biol.
(2002) - et al.
Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease
J. Neuropathol. Exp. Neurol.
(2007) - et al.
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases
J. Neurol. Neurosurg. Psychiatry
(1992) - et al.
Lewy body pathology involves cutaneous nerves
J. Neuropathol. Exp. Neurol.
(2008)
Cited by (101)
Fluid and tissue biomarkers in Parkinson's disease: Immunodetection or seed amplification? Central or peripheral?
2024, Parkinsonism and Related DisordersAlpha-synuclein in skin as a high-quality biomarker for Parkinson's disease
2023, Journal of the Neurological SciencesRelevance of Biochemical Deep Phenotyping for a Personalised Approach to Parkinson's Disease
2023, NeuroscienceCitation Excerpt :It is easy to perform and can be repeated over time with minimal invasiveness. It is an interesting tool for stratification studies (Korecka et al., 2019; Carling et al., 2020), and also for detecting established biomarkers (Miki et al., 2010; Donadio et al., 2014; Miglis and Muppidi, 2020) and identifying new ones, to improve PD diagnosis, patient-targeted therapy and patient follow up. Some skin biopsy studies focused on detecting phosphorylated αSyn deposits in nerve fibres in the skin.
Skin biopSYN or how to predict Parkinson's disease
2021, Parkinsonism and Related DisordersCardiac electrical remodeling and neurodegenerative diseases association
2021, Life SciencesParkinson's disease and skin
2021, Parkinsonism and Related Disorders